BlackRock Fund Advisors - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 39 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$66,000
+10.0%
58,000
+16.0%
0.00%
Q3 2016$60,000
+17.6%
50,0000.0%0.00%
Q2 2016$51,00050,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
K2 PRINCIPAL FUND, L.P. 9,000$9,953,0000.83%
CSS LLC/IL 10,119,000$11,031,0000.46%
DeepCurrents Investment Group LLC 13,556,000$14,917,0000.45%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,000,000$11,014,0000.24%
WOLVERINE ASSET MANAGEMENT LLC 28,592,000$31,218,0000.24%
HBK INVESTMENTS L P 14,616,000$15,971,0000.06%
PALISADE CAPITAL MANAGEMENT, LP 2,127,000$2,334,0000.05%
Verition Fund Management LLC 3,942,000$4,304,0000.04%
LAZARD ASSET MANAGEMENT LLC 10,037,000$10,959,0000.01%
Calamos Advisors LLC 2,423,000$2,648,0000.01%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders